Blocking two tiny molecules of RNA – a chemical cousin of DNA – appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found.
Category: News
Laser Eye Center Of Carolina First To Offer IFS Laser In North Carolina
Laser Eye Center of Carolina (LECC) announced today that it has become the first and only medical facility in North Carolina to offer patients the benefits of the iFS femtosecond laser for corrective vision procedures such as corneal transplants, catar…
Laser Eye Center Of Carolina First To Offer IFS Laser In North Carolina
Laser Eye Center of Carolina (LECC) announced today that it has become the first and only medical facility in North Carolina to offer patients the benefits of the iFS femtosecond laser for corrective vision procedures such as corneal transplants, catar…
CMSC: Retinal Scans Eyed For Tracking MS
A common retinal imaging technology could eventually supplement or even replace MRI for tracking multiple sclerosis severity and progression, researchers suggested here.
Migraine Visual Auras Present in a Variety of Patterns
A new survey reveals that migraines result in a wide variety of aura symptoms. Medscape Medical News
Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement
Merge Healthcare, a leading provider of healthcare enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems, a leading provider of digital imaging and informatics solutions for ophthalmology and other medical specialties, today…
Positive data from Biogen Idec’s AVONEX clinical trial on multiple sclerosis presented at CMSC 2011
Biogen Idec today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like symptoms associated with the therapy.
Helping Children Succeed – EyeMed Vision Care Introduces EyeMed KidsEyes Vision Benefit
EyeMed Vision Care, one of the nation’s leading vision benefits companies and part of Luxottica (NYSE: LUX), a leader in vision care and eyewear, introduces a first-to-market vision benefit that is tailored to meet the unique needs of children 18 years…
Denali, Can-Fite sign agreement to conclude ophthalmology spinoff
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange, signed today an agreement to spin off its ophthalmic indications t…
Lucentis(R) (Ranibizumab) Launched In The UK For The Treatment Of Vision Loss Due To Macular Oedema Secondary To Retinal Vein Occlusion (RVO)
Novartis Pharmaceuticals UK Ltd today announced that Lucentis® (ranibizumab) has launched in the UK for the treatment of visual impairment due to macular oedema secondary to Retinal Vein Occlusion (RVO)…
VEGF Trap-Eye Submitted For EU Marketing Authorization For Treatment Of Wet Age-Related Macular Degeneration
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced thatBayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration…
New Accommodating Implants Expand Options For Presbyopia Correction
Accommodating lenses will become the preferred method of presbyopia correction, according to a speaker here.
A Change in Thinking: Do Not Enlarge the Cataract Wound When Things Go Downhill
Featured Article
NICE Recommends OZURDEX(R), An Innovative Treatment For Retinal Vein Occlusion (RVO), A Common Cause Of Vision Loss
Allergan announces today that the National Institute for Health and Clinical Excellence (NICE) has recommended OZURDEX® (dexamethasone 0.7mg intravitreal implant in applicator) for the treatment of macular oedema due to central retinal vein occlusion …
NICE Recommends OZURDEX®, An Innovative Treatment For Retinal Vein Occulsion (RVO), A Common Cause Of Vision Loss
Allergan announces today that the National Institute for Health and Clinical Excellence (NICE) has recommended OZURDEX® (dexamethasone 0.7mg intravitreal implant in applicator) for the treatment of macular oedema due to central retinal vein occlusion …
Drug Product Recall Due to Possible Penicillin Contamination
Concerns over potential cross-contamination of nonpenicillin drug products with penicillin have resulted in a nationwide recall of multiple repackaged products. Medscape Medical News
I’m Struggling to Live on $160,000 a Year: MD Lament
Whereas most Americans would consider a $160,000 income a fortune, many physicians find it a challenge to live on that amount. Why can some manage easily while others are struggling to pay the bills? Medscape Business of Medicine
Improved Understanding Of Lens Transparency, Identification Of Mutations That Cause Congenital Cataracts
New research identifies genetic mutations that cause an inherited form of cataracts in humans. The study, published online June 2 by Cell Press in the American Journal of Genetics, provides new insight into the understanding of lens transparency and th…
Scientists Identify Mutations That Cause Congenital Cataracts
New research identifies genetic mutations that cause an inherited form of cataracts in humans. The study, published online June 2 by Cell Press in the American Journal of Genetics, provides new insight into the understanding of lens transparency and th…
Femtosecond Laser Marks New Era In Cataract Surgery
Femtosecond laser-assisted cataract surgery could present a landmark moment in cataract surgery, according to a speaker here.